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Background and purpose — Antibiotic treatment of patients 
before specimen collection reduces the ability to detect organisms 
by culture. We investigated the suppressive effect of antibiotics on 
the growth of non-adherent, planktonic, and surface-related bio-
fi lm bacteria in vitro by using sonication and microcalorimetry 
methods.
Patients and methods — Biofi lms of Staphylococcus aureus, S. 
epidermidis, Escherichia coli, and Propionibacterium acnes were 
formed on porous glass beads and exposed for 24 h to antibiotic 
concentrations from 1 to 1,024 times the minimal inhibitory con-
centration (MIC) of vancomycin, daptomycin, rifampin, fl ucloxa-
cillin, or ciprofl oxacin. The beads were then sonicated to dislodge 
biofi lm, followed by culture and measurement of growth-related 
heat fl ow by microcalorimetry of the resulting sonication fl uid.
Results — Vancomycin did not inhibit the heat fl ow of staphy-
lococci and P. acnes at concentrations ≤ 1,024 µg/mL, whereas fl u-
cloxacillin at > 128 µg/mL inhibited S. aureus. Daptomycin inhib-
ited heat fl ow of S. aureus, S. epidermidis, and P. acnes at lower 
concentrations (32–128 times MIC, p < 0.001). Rifampin showed 
inconsistent results in staphylococci due to random emergence of 
resistance, which was observed at concentrations ≤ 1,024 times 
MIC (i.e. 8 µg/mL). Ciprofl oxacin inhibited heat fl ow of E. coli at 
≥ 4 times MIC (i.e. ≥ 0.06 µg/mL).
Interpretation — Whereas time-dependent antibiotics (i.e. 
vancomycin and fl ucloxacillin) showed only weak growth sup-
pression, concentration-dependent drugs (i.e. daptomycin and 
ciprofl oxacin) had a strong suppressive effect on bacterial growth 
and reduced the ability to detect planktonic and biofi lm bacte-
ria. Exposure to rifampin rapidly caused emergence of resistance. 
Our fi ndings indicate that preoperative administration of antibi-
otics may have heterogeneous effects on the ability to detect bio-
fi lm bacteria.
■
Prosthetic joint infection (PJI) is a serious complication with 
a reported incidence rate of 0.6–2.2% (Dale et al. 2012, Kurtz 
et al. 2012). The true incidence can be expected to be higher, 
though, due to under-reporting in the national databases (Huo-
tari et al. 2010, Gundtoft et al. 2015) and imperfect diagnostic 
methods (Zimmerli et al. 2004). 
For successful treatment, the diagnostic procedure involves 
isolation of the causative organism (Kamme and Lindberg 
1981, Spangehl et al. 1999). Microorganisms living on the 
biologically inert surfaces of prosthetic components pro-
duce an organized community called biofi lm (Gbejuade et 
al. 2014). These adherent biofi lm bacteria can withstand host 
immune responses and are much less susceptible to antibiotics 
than their non-adherent, planktonic counterparts (Costerton et 
al. 1999). 
Biofi lm bacteria are often inaccessible with conventional 
sampling of synovial fl uid and periprosthetic tissue samples, 
especially after eradication of the non-adherent bacteria by 
previous antibiotic treatment—e.g. empirical antibiotic ther-
apy during postoperative wound healing complications or pre-
vious infections (Berbari et al. 2007, Malekzadeh et al. 2010). 
This has led to the use of sonication, which was introduced 
to improve the sensitivity of culture from biofi lm infections 
by dislodgement of adherent bacteria from implant surfaces 
(Trampuz et al. 2007a).
To address the challenges of detecting slow-growing bacte-
ria and reduced bacterial numbers after previous exposure to 
antibiotic, isothermal microcalorimetry has been found to be 
a highly sensitive and accurate method (Trampuz et al. 2007b, 
von Ah et al. 2008, Furustrand Tafi n et al. 2012a, Maiolo et 
al. 2014). The principle of microcalorimetry relies on micro-
bial heat production from bacterial growth and metabolism 
(Boling et al. 1973). Real-time measurement of exponential 
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bacterial growth results in a pyramid-shaped heat-fl ow curve. 
The effect of antibiotics on recovery of bacterial growth can 
be followed by delayed detection of heat fl ow and reduction 
of the peak heat fl ow (Furustrand Tafi n et al. 2011, Furustrand 
Tafi n et al. 2012b, Mihailescu et al. 2014). 
The main aim of this study was to determine the antimicro-
bial susceptibility of tested planktonic and biofi lm bacteria in 
order to correlate biofi lm detection with antibiotic exposure. A 
secondary aim was to investigate the effect of antibiotic expo-
sure on detection of biofi lm bacteria by sonication, culture, 
and microcalorimetry. We specifi cally investigated the effects 
of individual antibiotics in inhibiting the growth of planktonic 
and biofi lm bacteria. Microcalorimetric measurement of heat 
fl ow was compared with conventional viable counting of dis-
lodged biofi lm bacteria.
 
Material and methods
This experimental study was designed to determine the effect 
of different antibiotics that are usually used in the treatment 
of PJI on the detection of biofi lm bacteria by sonication and 
microcalorimetry, and to compare these results with those 
from conventional quantitative culture. 
Test organisms and antimicrobial agents
Laboratory strains of bacteria that commonly cause PJI were 
studied, including methicillin-susceptible Staphylococcus 
aureus (ATCC 29213), methicillin-resistant Staphylococ-
cus epidermidis (ATCC 35984), Propionibacterium acnes 
(ATCC 11827), and Gram-negative ciprofl oxacin-suscepti-
ble Escherichia coli (ATCC 25922). Bacterial strains were 
stored at −80°C and cultured overnight on sheep blood agar 
plates before each experiment. Anaerobic culture conditions 
(Anaerogen system; Oxoid) and prolonged incubation (72 h) 
were used for all experiments with P. acnes in order to get 
visible colonies. The following antibiotics were used: vanco-
mycin (Teva Pharma AG), daptomycin (Novartis Pharma AG), 
rifampin (Sandoz AG), fl ucloxacillin (Actavis SA), and cip-
rofl oxacin (Bayer AG). For comparative reasons, the minimal 
inhibitory concentration (MIC) was initially determined for 
each combination of antibiotics and bacteria according to the 
Clinical and Laboratory Standards Institute (CLSI) guidelines 
(CLSI 2012).
Biofi lm formation on glass beads
Biofi lms were investigated using porous glass beads (Vit-
raPOR; Robu Glasfi lter-geräte GmbH; diameter 4 mm, pore 
size 40–100 µm) (Corvec et al. 2013). For biofi lm formation, 
beads were placed in 50-mL Falcon tubes containing tryptic soy 
broth (TSB) (1 mL per bead) and inoculated with 2 CFU of 
microorganisms as specifi ed above. The beads were then incu-
bated aerobically for 24 h at 37°C (brain heart infusion (BHI), 
72 h, anaerobically for P. acnes). After the incubation, they 
were washed 5 times through rinsing with 10 mL saline, gentle 
shaking, and aspiration in order to minimize carryover of plank-
tonic and loosely attached bacteria on the biomaterial surface.
Antibiotic exposure of biofi lm
2-fold dilutions of antibiotic were prepared in TSB, or BHI for 
P. acnes, with concentrations ranging from 1 MIC up to 1,024 
times MIC. Beads with biofi lm bacteria were transferred with 
sterile forceps to the individual tubes (containing TSB and 
different antibiotic concentrations) and incubated for 24 h at 
37°C (anaerobically, 72 h for P. acnes). Experiments were 
performed independently in triplicate and were accompanied 
with a growth control consisting of an inoculated glass bead 
without antibiotics and one negative control of a sterile glass 
bead in antibiotic-free medium.
Removal of biofi lm by sonication
After exposure to antibiotic, the beads were transferred to 
individual Eppendorf tubes with 1 mL saline, vortexed for 
30 s with maximum power (Vortex Genie 2; Scientifi c Indus-
tries), sonicated for 60 s (BactoSonic; Bandelin Electronic), 
and vortexed for 30 s again to dislodge biofi lm-embedded bac-
teria. For conventional culture, 50-µL samples of the result-
ing sonication fl uid were serially diluted and plated on blood 
agar plates. Bacteria in the sonication fl uid were quantifi ed by 
viable count of colony-forming units per mL (CFU/mL).
Detection of dislodged bacteria by microcalorimetry
In parallel to taking viable counts, 0.1 mL of sonication fl uid 
from each experiment was added to 4-mL microcalorimetry 
glass ampoules with 1 mL TSB (3.9 mL BHI for P. acnes) 
(Clauss et al. 2010, Furustrand Tafi n et al. 2012b, Corvec et 
al. 2013). After sealing the ampoules, they were lowered into 
a 48-channel batch microcalorimeter (thermal activity moni-
tor model 3102 TAM III; TA Instruments). Heat fl ow (in µW) 
at 37.0000°C was measured continuously for 24 h (72 h for P. 
acnes) with an analytical sensitivity of ± 0.2 µW. The experi-
mental detection limit was set at 10 µW to distinguish micro-
bial heat production from the thermal background. Time to 
detection (TTD) was defi ned as the length of time (in hours) 
for a microcalorimeter experiment to reach the detection limit, 
which was therefore inversely proportional to the initial quan-
tity of bacteria and the growth rate. The results were plot-
ted as heat fl ow over time using the manufacturer’s software 
(TAM Assistant; TA Instruments) and Prism 7.0 (GraphPad 
Software, San Diego, CA). The minimal heat inhibitory con-
centration (MHIC) was defi ned as the lowest antibiotic con-
centration (in µg/mL) to kill bacteria on the beads, or to show 
a post-antibiotic effect of inhibiting bacterial growth, leading 
to absence of heat production from biofi lm-dislodged bacte-
ria after 24 h of incubation in the microcalorimeter (72 h for 
P. acnes). In relation to the MIC of planktonic bacteria, the 
MHIC value is a multiplication factor on an ordinal scale from 
1 MIC to 1,024 times MIC.
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Statistics
Experiments were performed in triplicate, and descriptive 
statistics were used to express the median and range of all 
data. Non-parametric comparisons of antimicrobial suscepti-
bility in 3 Gram-positive microorganisms were based on the 
multiplication factors and they were performed by Wilcoxon 
signed-rank test using GraphPad Prism 7.0. Direct comparison 
with the MHIC of ciprofl oxacin in Gram-negative bacteria (E. 
coli) was deemed unsuitable.
Results
Susceptibility of planktonic and dislodged biofi lm 
bacteria to antibiotics
The Table summarizes the inhibition of microbial growth, 
expressed as the antimicrobial susceptibility of biofi lm bac-
teria—as determined by sonication and microcalorimetry 
(MHIC)—relative to the MIC of planktonic bacteria. MHIC 
was considerably higher than MIC for all test strains and 
antibiotics (4 times to more than 1,024 times). According to 
CLSI breakpoints, the bacterial strains were susceptible to all 
antibiotics tested. The MHIC for vancomycin was more than 
1,024 µg/mL for both staphylococci and P. acnes. The high 
MHIC values for rifampin refl ect the emergence of resistance 
in staphylococci and P. acnes, as confi rmed by susceptibility 
testing of the organisms after antibiotic exposure. The MHIC 
values were lowest for ciprofl oxacin in E. coli (0.063 µg/mL), 
except in 1 of 5 experiments, where the MHIC was 0.25 µg/
mL, refl ecting emergence of ciprofl oxacin resistance. In rela-
tion to the multiplication factor, the MHIC of daptomycin in 
Gram-positive bacteria was signifi cantly lower than that of 
vancomycin (p < 0.001), rifampin (p < 0.001), and fl ucloxa-
cillin (p = 0.03).
Effect of antibiotic exposure on detection of biofi lm 
bacteria by microcalorimetry
Figure 1 shows the heat fl ow of bacteria after exposure to anti-
biotic, as a function of time. The heat-fl ow curves of organ-
isms without previous antibiotic exposure had specifi c charac-
teristics for each test bacterium, including the peak heat fl ow 
and shape of the curve. The time-shift of the curves to the 
right shows the delayed bacterial detection due to the lower 
quantity of bacteria in the sonication fl uid from beads exposed 
to increasing concentrations of vancomycin, daptomycin, 
rifampin, fl ucloxacillin (only for S. aureus), and ciprofl oxacin 
(only for E. coli). With rifampin, emergence of resistance was 
observed in S. aureus (Figure 1C) and S. epidermidis (Figure 
1G) from heat production at higher antibiotic concentrations.
Figure 2 shows the time to heat detection. Fast-growing, 
high-virulence bacteria such as S. aureus (Figure 2A–D) and 
E. coli (Figure 2H) are detected earlier and produce a higher 
peak of heat fl ow compared to less virulent and more slowly 
growing bacteria (S. epidermidis (Figure 2E–G) and P. acnes 
(Figure 2I–K)). In addition, we observed the different modes 
of action of the antibiotics tested. Exposure to fast-acting 
antibiotics (such as daptomycin, rifampin, and ciprofl oxacin) 
resulted in inhibition of heat fl ow at lower concentrations rela-
tive to the MIC and a more potent anti-biofi lm activity com-
pared to more slowly acting drugs (such as vancomycin and 
fl ucloxacillin). The high variability in heat fl ow after exposure 
to rifampin was due to spontaneous development of resistance, 
as confi rmed by susceptibility testing.
In parallel to the microcalorimetric assay, the presence of 
bacteria in the sonication fl uid was assessed by viable counts 
on conventional cultures (also shown in Figure 2). The culture 
results from repeated experiments with S. aureus (Figure 2C) 
and S. epidermidis (Figure 2G) exposed to rifampin showed 
a high degree of heterogeneity due to random emergence of 
resistance, and the data are therefore not shown.
Discussion
A correct and timely microbial diagnosis is a crucial step 
in determining the treatment of PJI, but antibiotic treatment 
before collection of periprosthetic tissue samples may lead 
to false-negative culture results (Kamme and Lindberg 1981, 
Spangehl et al. 1999, Trampuz et al. 2004, Achermann et al. 
2010). In the present study, we investigated the effect of expo-
Susceptibility of test organisms to vancomycin, daptomycin, rifampin, fl ucloxacillin, and ciprofl oxacin. The results are 
expressed as minimal inhibitory concentration (MIC) for non-adherent, planktonic bacteria and as minimal heat inhibi-
tory concentration (MHIC) for biofi lm bacteria. Numbers are in µg/mL
 Vancomycin Daptomycin Rifampin Flucloxacillin Ciprofl oxacin
Organism MIC MHIC MIC MHIC MIC MHIC MIC MHIC MIC MHIC
S. aureus 1 > 1,024 0.5 64 0.007 8 0.25 128 ND ND
S. epidermidis 2 > 1,024 1 64 0.007 8–16 a IR IR ND ND
E. coli IR IR IR IR IR IR IR IR 0.015 0.063–0.25 a
P. acnes 1 > 1,024 1 32 0.007 8–16 a ND ND ND ND
IR, intrinsic resistance; ND, not done.
a In 3 cases where small variations were observed in experiments done in triplicate, the results are given as range.
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sure of a young (24-h) biofi lm on porous glass beads to anti-
biotic under in vitro conditions, using sonication and micro-
calorimetry.
We believe that this experimental study has clinical rele-
vance regarding the challenge of establishing a bacterial diag-
nosis in cases with previous exposure to antibiotics (e.g. in 
recurrent infections or antibiotic prophylaxis). 
Our materials included 4 bacteria that commonly cause 
PJI (Zappe et al. 2008, Stefansdottir et al. 2009), but which 
have differences in virulence pattern, metabolism, and Gram-
stainability. Empirical antimicrobial treatment for PJI may 
include vancomycin and fl ucloxacillin for Gram-positive 
microorganisms or ciprofl oxacin for Gram-negative microor-
ganisms (Zimmerli and Moser 2012). Specifi c combinations 
with biofi lm-penetrating rifampin are recommended under 
certain circumstances, and novel antibiotics such as daptomy-
cin have been introduced in recent therapeutic studies (Zim-
merli and Moser 2012). The rationale for antibiotic selection 
in this study was to test drugs with different properties regard-
ing mode of action (concentration- or time-dependent), bac-
tericidal activity (fast- or slow-killing), and existence of anti-
biofi lm activity (Asin et al. 2012).
The limitations of our study design included lack of impor-
tant in vivo information about conditions such as antimicrobial 
pharmacokinetics (dose, tissue penetration, repeated admin-
istration, duration of treatment), the host immune response, 
and the fact that the artifi cial porosity of glass beads might 
not necessarily refl ect that of commonly used prosthetic mate-
rial. Also, we did not try to investigate the sonication fl uid for 
the possible presence of viable—but non-cultivable—bacteria 
that produce less metabolism-related and growth-related heat 
fl ow.
Concerning antimicrobial susceptibility testing, for all test 
strains and antibiotics, the biofi lm bacteria were 4 to > 1,024 
times more resistant than non-adherent, planktonic bacteria, 
as determined by comparison of microcalorimetry (MHIC) 
and the MIC. The low doses achieved with systemic antibi-
otic therapy may alleviate symptoms caused by planktonic 
bacteria, but this barely affects the biofi lm bacteria (Costerton 
2005). According to CLSI breakpoints, the planktonic strains 
were susceptible to all the antibiotics tested. The MHIC for 
vancomycin was > 1024 µg/mL in the case of staphylococci 
and P. acnes biofi lms. Vancomycin has previously been found 
to be less effective against staphylococcal biofi lms (Monzon et 
Figure 1. Heat fl ow (y-axis, µW) 
development over time (x-axis, 
hours) of S. aureus (panels A–D), 
S. epidermidis (E–G), E. coli (H), 
and P. acnes (I–K) exposed to dif-
ferent antibiotics. The numbers 
above each curve indicate the 
respective antibiotic concentra-
tions. The range for x-axis is dif-
ferent in the case of P. acnes (72 
h). Furthermore, y-axis range was 
changed for non-staphylococci 
that showed markedly different heat fl ow levels. The positive controls were biofi lms on beads not previously exposed to antibiotics (0 µg/mL). The 
experiments were performed in triplicate, and a representative experiment is shown.
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al. 2002, Molina-Manso et al. 2013). The inconsistently high 
MHIC values for rifampin refl ect the random emergence of 
resistance in staphylococci and P. acnes, as confi rmed by sus-
ceptibility testing of the organisms after antibiotic exposure. 
The observation of spontaneous development of resistance to 
rifampin shows that a high bacterial concentration is a risk 
factor for emergence of resistance. These results confi rm that 
rifampin should not be used as a single therapy or before suf-
fi cient surgical debridement, as has been recommended previ-
ously (Zimmerli et al. 2004, Furustrand Tafi n et al. 2012b). 
The MHIC values were lowest for ciprofl oxacin in E. coli 
(0.063 µg/mL), except in 1 of 5 experiments, where the MHIC 
was 0.25 µg/mL—refl ecting the emergence of ciprofl oxacin 
resistance. 
Concerning the effect of antibiotic exposure on detection 
of biofi lm bacteria, vancomycin did not reduce the ability to 
detect staphylococci and P. acnes in biofi lms, even at very 
high (non-physiological) concentrations. Thus, our results 
call into question the short-term (24-hour) effect of vanco-
mycin, which is often used in bone cement spacer to give 
high local concentrations, on eradication of biofi lm bacteria. 
Daptomycin was the most active antibiotic, inhibiting staphy-
lococci at 64 µg/mL and P. acnes at 32 µg/mL. Ciprofl oxa-
cin inhibited E. coli even at very low concentrations (MHIC 
0.063 µg/mL). Flucloxacillin and rifampin inhibited Gram-
positive bacteria, but only at higher concentrations than the 
MIC. The high culture yield from sonication fl uid found in 
this study suggests that sonication is an effi cient method to 
facilitate detection of biofi lm bacteria despite antibiotic expo-
sure (Trampuz et al. 2007a). However, our fi ndings also sug-
gest that using concentration-dependent antibiotics preopera-
tively may reduce the ability of a sonication-based method to 
detect the bacteria, whereas time-dependent antibiotics may 
be safer.
A recent randomized clinical trial did not fi nd impaired 
intraoperative culture results in PJI as a consequence of using 
single-dose antibiotic prophylaxis (Tetreault et al. 2014). The 
authors suggested that perioperative antibiotic prophylaxis 
should be administered before surgery and before intraop-
erative sampling. We investigated a young (24-hour) biofi lm, 
which might not be entirely relevant to the clinical situation 
where infection has usually been present for more than 24 
hours. Under these conditions, it appears that a single dose 
of antibiotics does not reduce the sensitivity of a sonication-
culture method. Whether this would also be true for mature 
biofi lms remains to be elucidated. 
Figure 2. Growth inhibition of 
various antibiotics on S. aureus 
(panels A–D), S. epidermidis 
(E–G), E. coli (H), and P. acnes 
(I–K) in sonication fl uid, deter-
mined by microcalorimetry 
and culture. The x-axis shows 
increasing antibiotic concentra-
tions (µg/mL). The green line 
represents median bacterial 
concentration (corresponding to 
y-axis on right, in CFU/mL) determined by viable count in 3 independent experiments; bars indicate range. The blue line represents median time 
to detection (corresponding to y-axis on left, in hours) in the microcalorimeter experiment. It demonstrates how signifi cant bacterial heat fl ow (> 
10 µW) is detectable within a few hours. Spontaneous emergence of staphylococcal resistance to rifampin was observed in replicates of experi-
ments C and G.
Acta Orthopaedica 2016; 87 (6): 644–650 649
The combined action of sonication and microcalorimetry 
might be useful in investigation of pre-exposure of biofi lm-
embedded bacteria to antibiotic. Furthermore, the high inter-
experimental repeatability of the microcalorimetry assay in 
this and other studies suggests that the method is a valid test 
for investigation of dislodged biofi lms (Clauss et al. 2010, 
Borens et al. 2013). Additional advantages of microcalorime-
try are the fast detection of heat fl ow (within a few hours) from 
microbial metabolism in sonication fl uid and real-time evalua-
tion of the interaction between antibiotics and biofi lm bacteria 
(Furustrand Tafi n et al. 2011). The accurate measuring tem-
perature controlled at ± 0.0001°C allows an analytical sensi-
tivity of ± 0.2 µW, but in this study the experimental detection 
limit was determined at 10 µW to distinguish microbial heat 
production from the thermal background (e.g. non-specifi c 
heat fl ow generated by degradation of the growth medium). 
Time to detection was defi ned as the duration of a microcal-
orimetry experiment to reach 10 µW, and was therefore not 
equivalent to the earliest sign of increase in heat fl ow. TTD is 
inversely proportional to the initial quantity and growth rate 
of bacteria, and we cannot exclude the possibility that discrete 
metabolism in viable but non-cultivable bacteria is neglected 
because of this detection limit.
In conclusion, biofi lm bacteria are less susceptible to antibi-
otics than their non-adherent, planktonic counterparts. Weak 
growth inhibition was demonstrated with the time-dependent 
antibiotics (vancomycin and fl ucloxacillin), whereas the con-
centration-dependent drugs daptomycin and ciprofl oxacin 
considerably reduced the ability to detect biofi lm bacteria. 
These fi ndings appear to support a recommendation of thor-
ough surgical debridement in order to reduce the bacterial 
load rather attempts to cure an implant-related deep infection 
with antimicrobial therapy (Zimmerli et al. 2004).
Seen from a diagnostic point of view, these results might 
also indicate that preoperative administration of antibiotics 
has heterogeneous effects on the ability to detect biofi lm bac-
teria. The quantitative and highly reproducible outcome of 
these procedures calls for further research in diagnosis and 
treatment of implant-related infections.
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